These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8879475)

  • 21. Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.
    Paton C; Esop R; Young C; Taylor D
    Acta Psychiatr Scand; 2004 Oct; 110(4):299-305. PubMed ID: 15352932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
    Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
    Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone-associated increase in triglyceride levels.
    Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
    Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
    [No Abstract]   [Full Text] [Related]  

  • 24. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
    Baskak SC; Ozsan H; Baskak B; Devrimci Ozgüven H; Kinikli G
    Turk Psikiyatri Derg; 2008; 19(1):5-12. PubMed ID: 18330738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.
    van Berckel BN; Hijman R; van der Linden JA; Westenberg HG; van Ree JM; Kahn RS
    Biol Psychiatry; 1996 Dec; 40(12):1298-300. PubMed ID: 8959296
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum free Fatty acids and glucose metabolism, insulin resistance in schizophrenia with chronic antipsychotics.
    Wang CJ; Zhang ZJ; Sun J; Zhang XB; Mou XD; Zhang XR; Shang XF; Zhang TQ
    Biol Psychiatry; 2006 Dec; 60(12):1309-13. PubMed ID: 16650386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
    Chen CK; Chen YC; Huang YS
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
    [No Abstract]   [Full Text] [Related]  

  • 29. [Weight gain and clozapine].
    Jalenques I; Tauveron I; Albuisson E; Audy V
    Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dyslipidemia and schizophrenia].
    Wetterling T; Schneider B; Weber B
    Psychiatr Prax; 2007 Jul; 34(5):223-9. PubMed ID: 17160750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiolytic properties of neuroleptic drugs.
    Balon R; Kabès J
    Agressologie; 1981 Nov; 22(D):9-10. PubMed ID: 6120666
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood stressors, parental expectation, and the development of schizophrenia.
    Mirsky AF; Ingraham LJ; Lowing PA
    Prog Exp Pers Psychopathol Res; 1992; 15():110-30. PubMed ID: 1364178
    [No Abstract]   [Full Text] [Related]  

  • 35. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
    Ritsner M; Gibel A; Ram E; Maayan R; Weizman A
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.
    Haro JM; Suarez D; Novick D; Brown J; Usall J; Naber D;
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):235-44. PubMed ID: 17137759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of centbutindole as an anti-psychotic agent.
    Doongaji DR; Sheth AS; Paul T; Parikh RM; Vahora SA; Apte JS; Desai NK; Upadhaya AK; Satoskar RS
    Indian J Med Res; 1983 Jul; 78():126-33. PubMed ID: 6139336
    [No Abstract]   [Full Text] [Related]  

  • 38. [Overcoming resistance to therapy in schizophrenia].
    Poliachenko AB; Mogilianskaia FN
    Vrach Delo; 1985 Aug; (8):110-1. PubMed ID: 2866630
    [No Abstract]   [Full Text] [Related]  

  • 39. Defining treatment resistance.
    Curtis V; Lucey JV
    Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):684. PubMed ID: 7907264
    [No Abstract]   [Full Text] [Related]  

  • 40. Allopurinol for treatment-resistant schizophrenia and epilepsy: a case report.
    Liang CS; Yang FW; Chiang KT; Ho PS
    Pharmacopsychiatry; 2010 Aug; 43(6):233-4. PubMed ID: 20486042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.